Oruka Therapeutics, Inc. ORKA Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s net change in cash?
- Oruka Therapeutics, Inc. (ORKA) reported net change in cash of $2.59M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s net change in cash changed year-over-year?
- Oruka Therapeutics, Inc.'s net change in cash decreased by 88.2% year-over-year, from $22M to $2.59M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s net change in cash?
- Over 3 years (2022 to 2025), Oruka Therapeutics, Inc.'s net change in cash has grown at a 10.3% compound annual growth rate (CAGR), from -$10.91M to -$14.64M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.